Literature DB >> 11258161

Out-patient parenteral antibiotic therapy (OPAT): clinical outcomes and adverse events.

S J Berman, E W Johnson.   

Abstract

A chart review was conducted of patients in a program featuring self directed, home infusion of antibiotics for serious infections utilizing an out-patient medical office for teaching, mixing of drugs, and monitoring of patients. 302 courses of out-patient parenteral antibiotic therapy (OPAT) were administered to 221 patients. Therapy was successful in 94% of the episodes. Objective adverse events were noted in 25% of patients. To maximize the chance for a successful outcome, treatment plans should be individualized and structured to include systematic monitoring for adverse effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258161

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  3 in total

1.  Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.

Authors:  Michael A Lane; Jonas Marschall; Susan E Beekmann; Philip M Polgreen; Ritu Banerjee; Adam L Hersh; Hilary M Babcock
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-09       Impact factor: 3.254

Review 2.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

3.  Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions.

Authors:  Theresa Madaline; Priya Nori; Wenzhu Mowrey; Elisabeth Zukowski; Shruti Gohil; Uzma Sarwar; Gregory Weston; Riganni Urrely; Matthew Palombelli; Vinnie Frank Pierino; Vanessa Parsons; Amy Ehrlich; Belinda Ostrowsky; Marilou Corpuz; Liise-Anne Pirofski
Journal:  Open Forum Infect Dis       Date:  2017-06-29       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.